HanAll Biopharma Reports Q2 2024 Financial Results and Provides Business Update PR Newswire Jul 26, 2024 11:00am
HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer PR Newswire Jul 15, 2024 11:00am